rhizoma arisaema
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2014 (NCT02545777)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rhizoma arisaema
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06697886 | Phase 3 | Nov 16, 2023 | Tasly Pharmaceuticals, Inc. |
| NCT02545777 | Phase 2 | May 1, 2014 | Peking University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Tasly Pharmaceuticals, Inc. | For profit | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1